Q32 Bio (QTTB) Earnings Date & Reports

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to restore healthy immune balance in patients with alopecia areata (AA) and other autoimmune and inflammatory diseases driven by immune dysfunction... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

QTTB is expected to report earnings to fall 43.20% to -30 cents per share on November 05

Q3'26

Est.

$-0.31

Q1'26

Beat

by $0.06

Q4'25

Beat

by $5.37

Q3'25

Beat

by $0.19

Q2'25

Beat

by $0.02

The last earnings report on May 05 showed earnings per share of -54 cents, beating the estimate of -60 cents. With 156.43K shares outstanding, the current market capitalization sits at 473.63M.

View a ticker or compare two or three

QTTB

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days